跳至主要内容
临床试验/EUCTR2015-001801-15-ES
EUCTR2015-001801-15-ES进行中(未招募)不适用

Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

FIBICO0 个研究点开始时间: 2015年10月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
FIBICO

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Male and female patients between the ages of 18 and 75 years;
  • 2) Adenocarcinoma of the colon, sigma and colon-sigma joint which represent cT4a/b in line with The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual;
  • 3) Lymph node involvement: N0, the presence of N1/2 according to the 7th edition of the AJCC is allowed, provided that they can be resectable;
  • 4) Metastatic extent: M0;
  • 5) Karnofsky index >70 o rPerformance status ?2;
  • 6) Informed consent properly completed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 190
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1) Presence of metastatasis (M1);
  • 2) Presence of unresectability criteria;
  • 3) Urgent intervention for obstruction or perforation;
  • 4) Extraperitoneal rectal cáncer (avoiding alterations for neoadyuvance);
  • 5) Coexistence with another malignant neoplastic disease;
  • 6) Severely altered liver, kidney and cardiovascular function;
  • 7) Intolerance to treatment;
  • 8) Administration of chemotherapy before the trial (use of neoadyuvance is discarded);
  • 9) Pregnant or breastfeeding women.

研究者

发起方
FIBICO

相似试验

进行中(未招募)
1 期
Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19
EUCTR2020-001530-35-ESFundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)450
已完成
不适用
A multicentre, randomised clinical trial to evaluate the efficacy of oral ciprofloxacin, oral tamsulosin, and the combination of oral ciprofloxacin and oral tamsulosin for the treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
ISRCTN85291415ational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIDDK, NIH) (USA)184
已完成
不适用
Fitness for the Ageing Brain Study II
ACTRN12609000755235The University of Melbourne230
进行中(未招募)
1 期
Clinical Trial to evaluate the effectivity and efficiency of preemptive genotyping before treatment with voriconazoleInvasive fungal disease in the hematologic patient.MedDRA version: 20.0 Level: HLGT Classification code 10017528 Term: Fungal infectious disorders System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0 Level: HLT Classification code 10040054 Term: Sepsis, bacteraemia, viraemia and fungaemia NEC System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0 Level: HLT Classification code 10029355 Term: Neutropenias System Organ Class: 100000004851MedDRA version: 20.0 Level: LLT Classification code 10076734 Term: Chemotherapy induced neutropenia System Organ Class: 100000004851MedDRA version: 20.1 Level: PT Classification code 10061187 Term: Haematopoietic neoplasm System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10059041 Term: Allogeneic peripheral haematopoietic stem cell transplant System Organ Class: 100000004865MedDRA version: 20.0 Level: LLT Classification code 10059040 Term: Autologous peripheral haematopoietic stem cell transplant System Organ Class: 100000004865
EUCTR2019-000376-41-ESFundación de Investigación del Hospital Universitario La Paz (FIBHULP)146
进行中(未招募)
1 期
Stem cell transplantation versus disease modifying therapy (alemtuzumab or ocrelizumab) for patients with highly active relapsing remitting MSHighly active relapsing remitting multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2019-001549-42-GBSheffield Teaching Hospitals198